Hence, we investigated multiplex bead-based immunoassay-technology measuring MMP7, MMP10 and MMP12 serum level in a homogenous collective of 78 patients suffering from colon cancer and a healthy control serum group to assess presumed differences in expression pattern and correlations with clinicopathological characteristics and survival. This evidence concerns the gene MMP7 and malignant colon neoplasm.